0001415889-23-006750.txt : 20230420 0001415889-23-006750.hdr.sgml : 20230420 20230420160547 ACCESSION NUMBER: 0001415889-23-006750 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230418 FILED AS OF DATE: 20230420 DATE AS OF CHANGE: 20230420 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Klein Matthew B. CENTRAL INDEX KEY: 0001808968 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35969 FILM NUMBER: 23833143 MAIL ADDRESS: STREET 1: C/O PTC THERAPEUTICS, INC. STREET 2: 100 CORPORATE COURT CITY: SOUTH PLAINFIELD STATE: NJ ZIP: 07080 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: PTC THERAPEUTICS, INC. CENTRAL INDEX KEY: 0001070081 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 043416587 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 100 CORPORATE COURT CITY: SOUTH PLAINFIELD STATE: NJ ZIP: 07080-2449 BUSINESS PHONE: 9082227000 MAIL ADDRESS: STREET 1: 100 CORPORATE COURT CITY: SOUTH PLAINFIELD STATE: NJ ZIP: 07080-2449 FORMER COMPANY: FORMER CONFORMED NAME: PTC THERAPEUTICS INC DATE OF NAME CHANGE: 19980909 4 1 form4-04202023_080437.xml X0407 4 2023-04-18 0001070081 PTC THERAPEUTICS, INC. PTCT 0001808968 Klein Matthew B. C/O PTC THERAPEUTICS, INC. 100 CORPORATE COURT SOUTH PLAINFIELD NJ 07080 false true false false CHIEF EXECUTIVE OFFICER 1 Common Stock 2023-04-18 4 A 0 26000 0 A 103856 D Common Stock 2023-04-18 4 S 0 1211 52.0437 D 102645 D Stock Option (Right to Buy) 52.96 2023-04-18 4 A 0 65000 0 A 2033-04-17 Common Stock 65000 65000 D Restricted stock units granted on April 18, 2023 that vest in four equal installments over four years, commencing on April 18, 2024. Represents shares automatically sold pursuant to an irrevocable sell to cover election to satisfy tax withholding obligations in connection with the vesting of 2,500 RSUs from an April 16, 2020 grant of 10,000 RSUs. This option was granted on April 18, 2023, and vests over four years, with 25% of the shares underlying the option vesting on April 18, 2024, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on July 18, 2024. /s/ Avraham S. Adler, Attorney-in-Fact 2023-04-20